Chickpea study: does hummus vs. pasta change how you burn energy?
NCT ID NCT06758869
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at how eating chickpeas in different forms—whole, pureed (like hummus), or as flour (like pasta)—affects how the body uses energy. Researchers will measure fat, carbohydrate, and protein burning in 204 healthy adults over 12 weeks. The goal is to understand if processing changes the health benefits of pulses.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- chickpea-based food products (whole chickpeas, pureed chickpeas, chickpea flour pasta)
- What this could lead to
- If successful, this could show that how a food is processed changes how our bodies use it for energy, which may help design healthier diets.
- What could go wrong
- This is an early-stage observational study in healthy people, not a treatment trial. Results may not apply to people with health conditions, and the effects might be small or hard to measure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
USDA Grand Forks Human Nutrition Research Center
Grand Forks, North Dakota, 58203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test